Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea

Journal of Infection

Volumn 60, Issue 2, 2010, Pages 146-153

  Lee, Mi Young ^a   Choi, Hyeon Jin ^b   Choi, Ji Young ^b   Song, Minsuk ^c   Song, Yoosuk ^c   Kim, Shin Woo ^d   Chang, Hyun Ha ^d   Jung, Sook In ^e   Kim, Yeon Sook ^f   Ki, Hyun Kyun ^g   Son, Jun Seong ^h   Kwon, Ki Tae ⁱ   Heo, Sang Taek ^j   Yeom, Joon Sup ^k   Shin, Sang Yop ^l   Chung, Doo Ryeon ^b   Peck, Kyong Ran ^b   Song, Jae Hoon ^a,b   Ko, Kwan Soo ^a,b  

^a Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Trinity Pawling School   (United States)

^d Kyungpook National University Hospital   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Konkuk University Hospital   (South Korea)

^h Kyung Hee University College of Medicine   (South Korea)

ⁱ Daegu Fatima Hospital   (South Korea)

^j Gyeongsang National University School of Medicine   (South Korea)

^k Sungkyunkwan University School of Medicine   (South Korea)

^l Jeju National University   (South Korea)

more..

Author keywords

Multilocus sequence typing (MLST); ST131; ST393; Surveillance

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ESCHERICHIA COLI PROTEIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN CTX M; PROTEIN PAPA; PROTEIN PAPG; PROTEIN TRAT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CIPROFLOXACIN RESISTANT ESCHERICHIA COLI; COMMUNICABLE DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE SEQUENCE; KOREA; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CIPROFLOXACIN; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 75549085056     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.11.004     Document Type: Article

References (25)

1. Lautenbach E., Fishman N.O., Metlay J.P., Mao X., Bilker W.B., Tolomeo P., et al. Phenotypic and genotypic characterization of fecal Escherichia coli isolates decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis 2006, 194:79-85.
2. Livermore D.M. Minimizing antibiotic resistance. Lancet Infect Dis 2005, 5:450-459.
3. Ko K.S., Suh J.Y., Peck K.R., Lee M.Y., Oh W.S., Kwon K.T., et al. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum β-lactamase-producing Escherichia coli isolated from urine and blood. Diagn Microbiol Infect Dis 2007, 58:111-115.
4. Lee S.J., Lee S.D., Cho I.R., Sim B.S., Lee J.G., Kim C.S., et al. Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002. Int J Antimicrob Agents 2004, 24S:S61-S64.
5. Grude N., Strand L., Mykland H., Nowrouzian F.L., Nyhus J., Jenkins A., et al. Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread. Clin Microbiol Infect 2007, 14:498-500.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th informational supplement 2007, Document M100-S17, CLSI, Wayne, Pa, USA.
7. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
8. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000, 181:261-272.
9. Moreno E., Planells I., Prats G., Planes A.M., Moreno G., Andreu A., et al. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia vs. strains causing pyelonephritis and other sources of bacteremia. Diagn Microbiol Infect Dis 2005, 53:93-99.
10. Lau S.H., Reddy S., Cheesbrough J., Bolton F.J., Willshaw G., Cheasty T., et al. Major uropathogenic Escherichia coli strain identified in the North West of England by multilocus sequence typing. J Clin Microbiol 2008, 46:1076-1080.
11. Sorlozano A., Gutierrez J., Jimenez A., Juan D.D.L., Jose Luis M. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates. J Clin Microbiol 2007, 45:2740-2742.
12. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
13. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006, 50:2872-2874.
14. Kim J., Lim Y.M., Rheem I., Lee Y., Lee J.C., Seol S.Y., et al. CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 2005, 245:93-98.
15. Ko K.S., Lee M.Y., Song J.H., Lee H., Jung D.S., Jung S.I., et al. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis 2008, 61:453-459.
16. Picard B., Garcia J.S., Gouriou S., Duriez P., Brahimi N., Bingen E., et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999, 67:546-553.
17. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibont V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273-281.
18. Cagnacci S., Gualco L., Debbia E., Schito G.C., Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008, 46:2605-2612.
19. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y., et al. Change in the prevalence of extended-spectrum β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72-79.
20. Leflon-Guibout V., Blanco J., Amaqdouf K., Mora A., Guize L., Nicolas-Chanoine M.H., et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008, 46:3900-3905.
21. Oelsen B., Scheutz F., Menard M., Skov M.N., Kolmos H.J., Kushowski M.A., et al. A three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol 2009, 46:1857-1862.
22. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agent Chemother 2002, 46:1-11.
23. Lee K., Lee M., Shin J.H., et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006, 12:44-49.
24. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006, 12:83-88.
25. Takahashi A., Muratani T., Yasuda M., Takahashi S., Monden K., Ishikawa K., et al. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAI usp subtypes, and mutation patterns. J Clin Microbiol 2009, 47:791-795.